Oral delivery of anti-PD-L1 antibody for cancer immunotherapy against orthotopic colorectal tumors
Authors:
- Linfu ChenLCLinfu Chen
- Lin ZhangLZLin Zhang
- Rui ZhaoRZRui Zhao
- Jingjing ShenJSJingjing Shen
- Yingyao WangYWYingyao Wang
- Jiafei ZhuJZJiafei Zhu
- Huapan FangHFHuapan Fang
- Nanhui LiuNLNanhui Liu
- Cheng WangCWCheng Wang
- Ting WeiTWTing Wei
- Yu ChaiYCYu Chai
- Maoyi LiMLMaoyi Li
- 25 March 2023
- journal article
- research article
- Published by Elsevier in Nano Today
- Vol. 50
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Immunogenic Cell Death in Cancer TherapyAnnual Review of Immunology, 2013
- Regulation of intestinal epithelial permeability by tight junctionsCellular and Molecular Life Sciences, 2012
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Cancer immunotherapy comes of ageNature, 2011
- Validation of a Static Franz Diffusion Cell System for In Vitro Permeation StudiesAAPS PharmSciTech, 2010
- Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 DiabetesDiabetes Care, 2010
- Safe and Effective Permeation Enhancers for Oral Drug DeliveryPharmaceutical Research, 2007
- Integrin signaling in epithelial cellsCancer Letters, 2007
- Challenges for the oral delivery of macromoleculesNature Reviews Drug Discovery, 2003
- Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinaseBiochemical Journal, 2002